162 related articles for article (PubMed ID: 26171607)
1. Altered CSMD1 Expression Alters Cocaine-Conditioned Place Preference: Mutual Support for a Complex Locus from Human and Mouse Models.
Drgonova J; Walther D; Singhal S; Johnson K; Kessler B; Troncoso J; Uhl GR
PLoS One; 2015; 10(7):e0120908. PubMed ID: 26171607
[TBL] [Abstract][Full Text] [Related]
2. Assessment of behaviors modeling aspects of schizophrenia in Csmd1 mutant mice.
Distler MG; Opal MD; Dulawa SC; Palmer AA
PLoS One; 2012; 7(12):e51235. PubMed ID: 23284669
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychological deficits in mice depleted of the schizophrenia susceptibility gene CSMD1.
Steen VM; Nepal C; Ersland KM; Holdhus R; Nævdal M; Ratvik SM; Skrede S; Håvik B
PLoS One; 2013; 8(11):e79501. PubMed ID: 24244513
[TBL] [Abstract][Full Text] [Related]
4. Mouse Model for Protein Tyrosine Phosphatase D (
Drgonova J; Walther D; Wang KJ; Hartstein GL; Lochte B; Troncoso J; Uetani N; Iwakura Y; Uhl GR
Mol Med; 2015 Nov; 21(1):717-725. PubMed ID: 26181631
[TBL] [Abstract][Full Text] [Related]
5. Cadherin 13: human
Drgonova J; Walther D; Hartstein GL; Bukhari MO; Baumann MH; Katz J; Hall FS; Arnold ER; Flax S; Riley A; Rivero-Martin O; Lesch KP; Troncoso J; Ranscht B; Uhl GR
Mol Med; 2016 Oct; 22():537-547. PubMed ID: 27579475
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253.
Donohoe G; Walters J; Hargreaves A; Rose EJ; Morris DW; Fahey C; Bellini S; Cummins E; Giegling I; Hartmann AM; Möller HJ; Muglia P; Owen MJ; Gill M; O'Donovan MC; Tropea D; Rujescu D; Corvin A
Genes Brain Behav; 2013 Mar; 12(2):203-9. PubMed ID: 23320435
[TBL] [Abstract][Full Text] [Related]
7. The CSMD1 genome-wide associated schizophrenia risk variant rs10503253 affects general cognitive ability and executive function in healthy males.
Koiliari E; Roussos P; Pasparakis E; Lencz T; Malhotra A; Siever LJ; Giakoumaki SG; Bitsios P
Schizophr Res; 2014 Apr; 154(1-3):42-7. PubMed ID: 24630139
[TBL] [Abstract][Full Text] [Related]
8. A genetic association study of CSMD1 and CSMD2 with cognitive function.
Athanasiu L; Giddaluru S; Fernandes C; Christoforou A; Reinvang I; Lundervold AJ; Nilsson LG; Kauppi K; Adolfsson R; Eriksson E; Sundet K; Djurovic S; Espeseth T; Nyberg L; Steen VM; Andreassen OA; Le Hellard S
Brain Behav Immun; 2017 Mar; 61():209-216. PubMed ID: 27890662
[TBL] [Abstract][Full Text] [Related]
9. No association between the rs10503253 polymorphism in the CSMD1 gene and schizophrenia in a Han Chinese population.
Liu Y; Cheng Z; Wang J; Jin C; Yuan J; Wang G; Zhang F; Zhao X
BMC Psychiatry; 2016 Jul; 16():206. PubMed ID: 27377754
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of cocaine-induced conditioned locomotion is associated with altered expression of hippocampal glutamate receptors in mice lacking LPA1 receptors.
Blanco E; Bilbao A; Luque-Rojas MJ; Palomino A; Bermúdez-Silva FJ; Suárez J; Santín LJ; Estivill-Torrús G; Gutiérrez A; Campos-Sandoval JA; Alonso-Carrión FJ; Márquez J; de Fonseca FR
Psychopharmacology (Berl); 2012 Mar; 220(1):27-42. PubMed ID: 21887497
[TBL] [Abstract][Full Text] [Related]
11. Characterization of genetically complex Collaborative Cross mouse strains that model divergent locomotor activating and reinforcing properties of cocaine.
Schoenrock SA; Kumar P; Gómez-A A; Dickson PE; Kim SM; Bailey L; Neira S; Riker KD; Farrington J; Gaines CH; Khan S; Wilcox TD; Roy TA; Leonardo MR; Olson AA; Gagnon LH; Philip VM; Valdar W; de Villena FP; Jentsch JD; Logan RW; McClung CA; Robinson DL; Chesler EJ; Tarantino LM
Psychopharmacology (Berl); 2020 Apr; 237(4):979-996. PubMed ID: 31897574
[TBL] [Abstract][Full Text] [Related]
12. Neural effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253.
Rose EJ; Morris DW; Hargreaves A; Fahey C; Greene C; Garavan H; Gill M; Corvin A; Donohoe G
Am J Med Genet B Neuropsychiatr Genet; 2013 Sep; 162B(6):530-7. PubMed ID: 23839771
[TBL] [Abstract][Full Text] [Related]
13. Differential Roles of Accumbal GSK3
Shi X; Barr JL; von Weltin E; Wolsh C; Unterwald EM
J Pharmacol Exp Ther; 2019 Nov; 371(2):339-347. PubMed ID: 31420527
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability.
Hatzimanolis A; Foteli S; Stefanatou P; Ntigrintaki AA; Ralli I; Kollias K; Nikolaou C; Gazouli M; Stefanis NC
Eur Arch Psychiatry Clin Neurosci; 2022 Oct; 272(7):1219-1228. PubMed ID: 35532796
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of the CSMD1 gene in the peripheral blood of schizophrenia patients.
Liu Y; Fu X; Tang Z; Li C; Xu Y; Zhang F; Zhou D; Zhu C
BMC Psychiatry; 2019 Apr; 19(1):113. PubMed ID: 30987620
[TBL] [Abstract][Full Text] [Related]
16. The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia.
Håvik B; Le Hellard S; Rietschel M; Lybæk H; Djurovic S; Mattheisen M; Mühleisen TW; Degenhardt F; Priebe L; Maier W; Breuer R; Schulze TG; Agartz I; Melle I; Hansen T; Bramham CR; Nöthen MM; Stevens B; Werge T; Andreassen OA; Cichon S; Steen VM
Biol Psychiatry; 2011 Jul; 70(1):35-42. PubMed ID: 21439553
[TBL] [Abstract][Full Text] [Related]
17. The Diverse Role of CUB and Sushi Multiple Domains 1 (CSMD1) in Human Diseases.
Ermis Akyuz E; Bell SM
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553598
[TBL] [Abstract][Full Text] [Related]
18. Conditioned drug reward enhances subsequent spatial learning and memory in rats.
Zhai HF; Zhang ZY; Zhao M; Qiu Y; Ghitza UE; Lu L
Psychopharmacology (Berl); 2007 Dec; 195(2):193-201. PubMed ID: 17661018
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Cocaine-Associated Contextual Learning in Female H/Rouen Mice Selectively Bred for Depressive-Like Behaviors: Molecular and Neuronal Correlates.
Rappeneau V; Morel AL; El Yacoubi M; Vaugeois JM; Denoroy L; Bérod A
Int J Neuropsychopharmacol; 2015 Mar; 18(8):. PubMed ID: 25733538
[TBL] [Abstract][Full Text] [Related]
20. Curious cases: Altered dose-response relationships in addiction genetics.
Uhl GR; Drgonova J; Hall FS
Pharmacol Ther; 2014 Mar; 141(3):335-46. PubMed ID: 24189489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
